David C. Remy

1.2k total citations
39 papers, 826 citations indexed

About

David C. Remy is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, David C. Remy has authored 39 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 6 papers in Molecular Biology and 5 papers in Pharmaceutical Science. Recurrent topics in David C. Remy's work include Asymmetric Synthesis and Catalysis (8 papers), Synthesis and pharmacology of benzodiazepine derivatives (8 papers) and Chemical synthesis and alkaloids (6 papers). David C. Remy is often cited by papers focused on Asymmetric Synthesis and Catalysis (8 papers), Synthesis and pharmacology of benzodiazepine derivatives (8 papers) and Chemical synthesis and alkaloids (6 papers). David C. Remy collaborates with scholars based in United States and Belgium. David C. Remy's co-authors include Charles Heidelberger, David G. Parsons, C. A. HUNT, David A. Claremon, Kenneth E. Rittle, Mark B. Freedman, Paul Anderson, Edward L. Engelhardt, Robert J. Lynch and Guixiang Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

David C. Remy

39 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Remy United States 16 401 206 150 109 66 39 826
James B. Doherty United States 19 646 1.6× 455 2.2× 33 0.2× 65 0.6× 24 0.4× 36 1.1k
Matthew W. D. Perry Sweden 19 513 1.3× 834 4.0× 58 0.4× 75 0.7× 68 1.0× 34 1.4k
Geeta Patel United Kingdom 18 224 0.6× 288 1.4× 25 0.2× 31 0.3× 25 0.4× 45 732
Michael N. Greco United States 18 489 1.2× 432 2.1× 20 0.1× 135 1.2× 33 0.5× 32 967
Joachim Blanz Germany 14 183 0.5× 536 2.6× 51 0.3× 98 0.9× 17 0.3× 31 967
Fumihiko Watanabe Japan 14 381 1.0× 310 1.5× 17 0.1× 43 0.4× 40 0.6× 35 860
Eric B. Sjogren United States 10 483 1.2× 737 3.6× 24 0.2× 59 0.5× 52 0.8× 13 1.4k
Michael R. Angelastro United States 13 306 0.8× 353 1.7× 96 0.6× 24 0.2× 24 0.4× 23 677
Robert B. Garland United States 15 479 1.2× 463 2.2× 35 0.2× 15 0.1× 54 0.8× 26 925
Wolfgang von der Saal Germany 16 357 0.9× 423 2.1× 36 0.2× 16 0.1× 29 0.4× 35 959

Countries citing papers authored by David C. Remy

Since Specialization
Citations

This map shows the geographic impact of David C. Remy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Remy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Remy more than expected).

Fields of papers citing papers by David C. Remy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Remy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Remy. The network helps show where David C. Remy may publish in the future.

Co-authorship network of co-authors of David C. Remy

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Remy. A scholar is included among the top collaborators of David C. Remy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Remy. David C. Remy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Remy, David C., et al.. (2004). Securing Web Services with WS-Security: Demystifying WS-Security, WS-Policy, SAML, XML Signature, and XML Encryption. CERN Document Server (European Organization for Nuclear Research). 48 indexed citations
2.
Liverton, Nigel J., David A. Claremon, David C. Remy, et al.. (1998). Nonpeptide glycoprotein IIb/IIIa inhibitors: Substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(5). 483–486. 105 indexed citations
3.
Wallace, Audrey A., Raymond F. Stupienski, Elizabeth Baskin, et al.. (1995). Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.. Journal of Pharmacology and Experimental Therapeutics. 273(1). 168–175. 27 indexed citations
4.
Gaul, Stanley L., David A. Claremon, David C. Remy, et al.. (1994). Transglutaminase Inhibition by 2-[(2-Oxopropyl)thio]imidazolium Derivatives: Mechanism of Factor XIIIa Inactivation. Biochemistry. 33(33). 10109–10119. 91 indexed citations
5.
Defraigne, Jean-Olivier, David C. Remy, Etienne Creemers, & Raymond Limet. (1991). Carotid-subclavian bypass with or without carotid endarterectomy.. PubMed. 90(5). 248–54. 13 indexed citations
6.
Bush, Larry R. & David C. Remy. (1988). Effects of 3-methoxycyproheptadine in a canine model of coronary thrombosis.. Journal of Pharmacology and Experimental Therapeutics. 247(2). 796–802. 2 indexed citations
7.
Remy, David C., Susan F. Britcher, Paul Anderson, et al.. (1983). Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives. Journal of Medicinal Chemistry. 26(7). 974–980. 16 indexed citations
8.
Girard, Yves, J. G. ATKINSON, Patrice C. Bélanger, et al.. (1983). Synthesis, chemistry and photochemical substitutions of 6,11-dihydro-5H-pyrrolo[2,1-b][3]benzazepin-11-ones. The Journal of Organic Chemistry. 48(19). 3220–3234. 52 indexed citations
9.
Remy, David C., Susan F. Britcher, Paul Anderson, et al.. (1982). Synthesis and orexigenic activity of some 1-methyl-4-piperidylidene-substituted pyrrolo[2,1-b][3]benzazepine and dibenzocycloheptene derivatives. Journal of Medicinal Chemistry. 25(3). 231–234. 2 indexed citations
10.
11.
12.
Christy, Marcia E., Paul Anderson, Susan F. Britcher, et al.. (1980). ChemInform Abstract: TRANSANNULAR REACTIONS OF DIBENZO(A,D)CYCLOALKENES. 1. SYNTHESIS OF DIBENZO(A,D)CYCLOOCTEN‐6,12‐IMINES AND DIBENZO(A,D)CYCLOHEPTEN‐5,10‐IMINES. Chemischer Informationsdienst. 11(3). 5 indexed citations
13.
Randall, William C., Paul Anderson, Emlen L. Cresson, et al.. (1979). Synthesis, assignment of absolute configuration, and receptor binding studies relevant to the neuroleptic activities of a series of chiral 3-substituted cyproheptadine atropisomers. Journal of Medicinal Chemistry. 22(10). 1222–1230. 20 indexed citations
14.
Christy, Marcia E., Paul Anderson, Susan F. Britcher, et al.. (1979). Transannular reactions of dibenzo[a,d]cycloalkenes. 1. Synthesis of dibenzo[a,d]cycloocten-6,12-imines and dibenzo[a,d]cyclohepten-5,10-imines. The Journal of Organic Chemistry. 44(18). 3117–3127. 19 indexed citations
15.
16.
Remy, David C., Kenneth E. Rittle, C. A. HUNT, et al.. (1977). Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine. Journal of Medicinal Chemistry. 20(8). 1013–1019. 8 indexed citations
17.
Remy, David C., Kenneth E. Rittle, C. A. HUNT, et al.. (1977). (+)- and (-)-3-Methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadine. Journal of Medicinal Chemistry. 20(12). 1681–1684. 14 indexed citations
18.
Remy, David C., et al.. (1975). Antiarrhythmic agents. 2-, 3-, and 4-Substituted benzylamines. Journal of Medicinal Chemistry. 18(2). 142–148. 6 indexed citations
19.
20.
Weisenborn, Frank L., David C. Remy, & Thomas L. Jacobs. (1954). Steroid Homologs Containing Pyridazinone and Related Nuclei1. Journal of the American Chemical Society. 76(2). 552–555. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James B. Doherty Breakdown of academic impact, for papers by Matthew W. D. Perry Breakdown of academic impact, for papers by Geeta Patel Breakdown of academic impact, for papers by Michael N. Greco Breakdown of academic impact, for papers by Joachim Blanz Breakdown of academic impact, for papers by Fumihiko Watanabe Breakdown of academic impact, for papers by Eric B. Sjogren Breakdown of academic impact, for papers by Michael R. Angelastro Breakdown of academic impact, for papers by Robert B. Garland Breakdown of academic impact, for papers by Wolfgang von der Saal
Rankless by CCL
2026